Healogix

Back to Our People

Harris Kaplan, Chairman and CEO
Harris Kaplan is Chief Executive Officer of Healogix, which he founded in 2004.

Harris has extensive experience in the pharmaceutical industry both on the client and consulting side of the business. Harris co-founded Migliara-Kaplan Associates which grew steadily under his leadership to become the world's largest custom marketing research company, serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify new product opportunities. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare.

Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an advisor to several venture capital funds and is on the Board of Directors of Informed Medical Communications, Informedix, and the Kernan Orthopedic Hospital.

Andrew Hall,
Andrew is founder of Black Tulip Group, an advisory and investment firm focused on the marketing, media and information services industries. Prior to forming Black Tulip, Andrew was Executive Vice President of WPP Group plc, the world's largest advertising & marketing services company where he worked between 1993 and 2000. Over this period, WPP enjoyed great success as a consolidator of the industry growing from around $2bn in revenue to around $7bn and being amongst the very best performing companies in the FTSE 100. Prior to joining WPP, Andrew worked in the UK with both Arthur Andersen & Co. and the Corporate Advisory Services Group of Ernst & Young. Mr. Hall holds an MBA from the London Business School, a BA in Economics & Finance from the University of Newcastle upon Tyne and an ACA qualification from the Institute of Chartered Accountants in England & Wales.


Tom Moore,
Thomas A. Moore is the CEO of Advaxis, a biotechnology company developing novel Listeria-based therapeutic cancer vaccines. Moore, 55, who has served on the Advaxis Board of Directors since September 2006 brings more than 25 years of experience in healthcare and general management. Mr. Moore is currently a board member of Alteon, Inc., a publicly traded developer of pharmaceuticals for the treatment of diabetes and age-related diseases, El Dorado Inc., a targeted marketer to unassimilated Hispanics, Medmeme, which measures medical education effectiveness, and Opt-e-scrip, Inc., which markets a clinical system to compare multiple drugs in the same patient. He also serves as Chairman of Mayan Pigments, Inc., which has developed and patented Mayan pigment technology. Previously, from June 2002 to June 2004 Mr. Moore was President and Chief Executive Officer of Biopure Corporation, a developer of oxygen therapeutics that are intravenously administered to deliver oxygen to the body's tissues. From 1996 to November 2000 he was President and Chief Executive Officer of Nelson Communications.

Previously, Mr. Moore had a 23-year career with the Procter & Gamble Company in multiple managerial positions, including President of Health Care Products where he was responsible for prescription and over-the-counter medications worldwide, and Group Vice President of the Procter & Gamble Company.